Considering above mentioned added value of combining a probe for CEP17 and a probe for the HER2/ERBB2 gene when performing HER2/ERBB2 gene ISH, we would like to advocate the use of a double probe ISH in favour of a single probe ISH in all breast carcinomas. This evidence concerns the gene ERBB2 and breast carcinoma.